| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 梅花集团是全球领先的氨基酸营养健康解决方案提供商。公司通过为全球100多个国家和地区多家知名客户提供各类氨基酸产品及使用解决方案，让全世界用户享有技术的全方位沟通。公司成立于2002年，注册地为西藏自治区拉萨市，全称“梅花生物科技集团股份有限公司”，2009年完成股份制改造，2010年底在沪市A股上市，办公地址位于河北省廊坊市，是目前国内氨基酸综合品类较多和产能较大的生产企业之一。 梅花集团拥有生物发酵行业中较完整的产业链和配套设施，通过全系列的研、产、供、销服务，灵活满足全球不同客户的差异化需求以及快速创新的追求，专注于打造生物发酵和生物制药的高端产业平台。2022年实现营业收入279亿元，归母净利润44.06亿，拥有1.2万员工，目前已完成河北、内蒙、新疆、吉林等多区域布局。 | ||||||||||||||||||||||||
| Main Business | 味精、氨基酸、有机肥等生物发酵领域 | ||||||||||||||||||||||||
| Legal Representative | 王爱军 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 刘现芳 | ||||||||||||||||||||||||
| Solicitors | 北京市天银律师事务所 | ||||||||||||||||||||||||
| Auditors | 大华会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0316-2359652 | ||||||||||||||||||||||||
| Fax No | 0316-2359670 | ||||||||||||||||||||||||
| Website | www.meihuagrp.com | ||||||||||||||||||||||||
| mhzqb@meihuagrp.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 17/02/1995 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 1.060 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.420 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 4.812 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 30.097B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |